Virus maturation as a new HIV-1 therapeutic target

Author： Adamson Catherine S Salzwedel Karl Freed Eric O

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.8, 2009-08, pp. : 895-908

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 10, 2016-04 ,pp. : 1154-1166

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 Integrase: A Target for New AIDS Chemotherapeutics

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 979-990

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 33-45

Bentham Science Publishers

Access to resources Recommend Favorite

The HIV-1 Tat Protein: A Multifaceted Target for Novel Therapeutic Opportunities

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 4, 2004-12 ,pp. : 277-285

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody responses and virus escape: implications for HIV-1 vaccine and therapeutic design

By Tomaras Georgia Shen Xiaoying Greenberg Michael

Future Virology, Vol. 1, Iss. 1, 2006-01 ,pp. : 79-88

Future Medicine

Access to resources Recommend Favorite